Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Symbiox Investment & Trading Company Ltd (NSE: SYMBIOX), ISIN INE653R01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SYMBIOX last traded at ₹2.00 (+0.00%), with a 52-week range of ₹1.36 to ₹3.70 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 3.33%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 43/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.